Abstract:
Thrombotic risk should be evaluated regularly in different clinical settings of cancer patients. Thromboprophylaxis with low molecular weight heparin (LMWH), being able to be complemented with mechanical means, or the alternative use of a inferior vein cave filter (FVCI) in the case of PE or acute proximal DVT of IBD, facing procedures that are contraindicated for anticoagulation, maintaining a certain thromboprophylaxis level, above other anticoagulants, is recommended for the majority of hospitalized cancer patients, although the safety of primary thromboprophylaxis in this context is unknown. Routine thromboprophylaxis in outpatients receiving chemotherapy is not recommended, except in outpatients who have other factors that condition high thrombosis, and thromboprophylaxis can be offered with apixaban, rivaroxaban, or low molecular weight heparin (LMWH) as long as there are no factors. risk factors for bleeding and without drug interactions. In patients who are going to undergo oncological surgery, thromboprophylaxis should start before surgery and continue for a minimum of 7 to 10 days, and in cases of major surgery, up to 4 weeks. Routine thromboprophylaxis in prevention of MMSS thrombosis in patients with central venous catheters (CVCs) is not recommended.

Biography:
Graduate of Medicine and Surgery in 1979, Autonomous University of Barcelona (UAB). Vall D´hebrón Teaching Unit. Bachelor of Medicine, UAB, in 1979
Internal Medicine Specialist, via MIR, 1984.
Sufficiency Research Diploma, University of Alcalá.
Doctor from the University of Alcalá, with Outstanding Cum Laude unanimous qualification.
Diploma from the UNED on Probability and Statistics in Medicine.
Diploma in Pedagogical Aptitude, C. Real School.
Postgraduate Diploma in Venous Thromboembolic Disease, 30 credits from the European Credit Trnasfer System, equivalent 750 hours, accredited by the Autonomous University of Barcelon (Fundación Doctor Robert)
-MASTER IN GETIÓN CLINICAL UNITS (University of Murcia), through the Spanish Society of Internal Medicine, Spanish Society of Respiratory Pathology, Spanish Society of Cardiology.- Official tutor of postgraduate training in Internal Medicine.
Head of Section of Internal Medicine from 1992 to 2005.

X